BBIO (NASDAQ: BBIO) trust sells repeated 20,000-share blocks under 10b5-1
Rhea-AI Filing Summary
Issuer filed a Form 144 reporting planned sales of Common Stock under 10b5-1 plans by trusts associated with Kumar Haldea. The filing lists multiple 10b5-1 dispositions of 20,000 shares each on dates including 03/12/2026, 03/13/2026, 04/09/2026, 04/10/2026, 05/07/2026, 05/08/2026, and a restricted stock unit entry dated 05/16/2026. Transactions were executed through Morgan Stanley Smith Barney LLC.
Positive
- None.
Negative
- None.
Insights
Form 144 lists repeated trust sales executed under 10b5-1 plans.
The excerpt documents multiple sales of Common Stock in 20,000-share increments by the Kumar Haldea Revocable Trust and the Kumar Haldea Family Irrevocable Trust on specific dates in 2026. Each row pairs a date with a 20,000-share disposition and an aggregate dollar amount.
These entries reflect planned dispositions reported via a Form 144 and routed through Morgan Stanley Smith Barney LLC; the filing constitutes a notice of proposed sale rather than confirmation of settlement amounts or remaining holdings.